ガイドライン

(旧版)科学的根拠に基づく急性胆管炎・胆嚢炎の診療ガイドライン

書誌情報
 
第X章 急性胆嚢炎 -基本的治療-


引用文献
1) Indar AA, Beckingham IJ.Acute cholecystitis. BMJ 2002 ; 25 : 639-43.(治療レベル2a)
2) Law CHL, Tandan VR.Gallstone disease : surgical treatment. Evidenced Based Gastroenterology and Hepatology. London : BMJ Books, 1999 : 260-70.(治療レベル1a)
3) Cameron IC, Chadwick C, Phillips J, Johnson AG. Acute cholecystitis room for improvement ? [comment]. Ann R Coll Surg Engl 2002 ; 4 : 10-3.(治療レベル4)
4) Akriviadis EA, Hatzigavriel M, Kapnias D, Kirimlidis J, Markantas A, Garyfallos A. reatment of biliary colic with diclofenac : a randomized, double-blind, placebo-controlled study. Gastroenterology 1997 ; 13 : 225-31.(治療レベル1b)
5) Goldman G, Kahn PJ, Alon R, Wiznitzer T. Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci 1989 ; 34 : 809-11.(治療レベル2b)
6) Lo CM, Liu CL, Fan ST, Lai EC, Wong J. Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg 1998 ; 227 : 461-7.(治療レベル2b)
7) Hazey JW, Brody FJ, Rosenblatt SM, Brodsky J, Malm J, Ponsky JL. Laparoscopic management and clinical outcome of emphysematous cholecystitis. Surg Endosc 2001 ; 15 : 1217-20.(治療レベル4)
8) Zeebregts CJ, Wijffels RT, de Jong KP, Peeters PM, Slooff MJ. Percutaneous drainage of emphysematous    cholecystitis associated with pneumoperitoneum. Hepatogastroenterol 1999 ; 46 : 771-4.(治療レベル4)
9) 内山勝弘,高田忠敬,安田秀喜.超音波分類からみた急性胆嚢炎治療法の選択に関する検討.胆道 1993 ; 6 : 115-22.(診断レベル2b)
10) Kiviniemi H, Makela JT, Autio R, Tikkakoski T, Leinonen S, Siniluoto T, et al. Percutaneous cholecystostomy in acute cholecystitis in high-risk patients : ananalysis of 69 patients. Int Surg 1998 ; 83 : 299-302.(治療レベル4)
11) Sugiyama M, Tokuhara M, Atomi Y. Is percutaneous cholecystostomy the optimal treatment for acute cholecystitis in the very elderly? World J Surg 1998 ; 22 : 459-63.(治療レベル4)
12) Chopra S, Dodd GD 3rd, Mumbower AL, Chintapalli KN, Schwesinger WH, Sirinek KR, et al. Treatment of acute cholecystitis in non-critically ill patients at high surgical risk : comparison of clinical outcomes after gallbladder aspiration and after percutaneous cholecystostomy. AJR 2001 ; 176 : 1025-31.(治療レベル4)
13) Akhan O, Akinci D, Ozmen MN. Percutaneous cholecystostomy. Eur J Radiol 2002 ; 43 : 229-36.(治療レベル4)
14) Hatzidakis AA, Prassopoulos P, Petinarakis I, Sanidas E, Chrysos E, Chalkiadakis G, et al. Acute cholecystitis in high-risk patients : percutaneous cholecystostomy vs conservative treatment. Eur Radiol 2002 ; 12 : 1778-84.(治療レベル2b)
15) 久津見弘,信谷健太郎,池澤 聡,西田憲生,塩見英之,葺屋悦子,他.胆嚢結石による急性胆嚢炎に対する経皮経肝的胆嚢穿刺吸引術の有用性.胆道 2004 ; 18 : 132-7.(治療レベル4)
16) Pitt HA, Postier RG, Cameron JL. Consequences of preoperative cholangitis and its treatment on the outcome of operation for choledocholithiasis. Surgery 1983 ; 94 : 447-52.(診断レベル2b)
17) Maluenda F, Csendes A, Burdiles P, Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. HepatoGastroenterol 1989 ; 36 : 132-5.(診断レベル3b)
18) Claesson BE. Microflora of the biliary tree and liver‐clinical correlates. Dig Dis 1986 ; 4 : 93-118.(診断レベル5)
19) Csendes A, Burdiles P, Maluenda F, Diaz JC, Csendes P, Mitru N. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch Surg 1996 ; 131 : 389-94.(診断レベル2b)
20) Csendes A, Mitru N, Maluenda F, Diaz JC, Burdiles P, Csendes P, et al. Counts of bacteria and pyocites of choledochal bile in controls and in patients with gallstones or common bile duct stones with or without acute cholangitis. HepatoGastroenterol 1996 ; 43 : 800-6.(診断レベル2b)
21) Csendes A, Becerra M, Burdiles P, Demian I, Bancalari K, Csendes P. Bacteriological studies of bile from the gallbladder in patients with carcinoma of the gallbladder, cholelithiasis, common bile duct stones and no gallstones disease. Eur J Surg 1994 ; 160 : 363-7.(診断レベル2b)
22) Csendes A, Fernandez M, Uribe P. Bacteriology of the gallbladder bile in normal subjects. Am J Surg 1975 ; 129 : 629-31.(診断レベル3b)
23) Kune GA, Schutz E. Bacteria in the billary tract. A study of their frequency and type. Med J Aust 1974 ; 1 : 255-8.(診断レベル3b)
24) Chang WT, Lee KT, Wang SR, Chuang SC, Kuo KK, Chen JS, Sheen PC. Bacteriology and antimicrobial susceptibility in biliary tract disease : an audit of 10-year's experience. Kaohsiung J Med Sci 2002 ; 18 : 221-8.(診断レベル3b)
25) Goswitz JT. Bacteria and Biliary Tract Disease. Am J Surg 1974 ; 128 : 644-6.(診断レベル4)
26) Farinon AM, Grande M, Torquati A, D'Antini P. Multivariate analysis for predicting the presence of bacteria in bile in patients with acute cholecystitis. Eur J Surg 1993 ; 159 : 531-4.(診断レベル1b)
27) Gerecht WB, Henry NK, Hoffman WW, Muller SM, LaRusso NF, Rosenblatt JE, et al. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med 1989 ; 149 : 1279-84.(治療レベル2b)
28) Muller EL, Pitt HA, Thompson JE Jr, Doty JE, Mann LL, Manchester B. Antibiotics in infections of the biliary tract. Surg Gynecol Obstet 1987 ; 165 : 285-92.(治療レベル2b)
29) Thompson JE Jr, Pitt HA, Doty JE, Coleman J, Irving C. Broad spectrum penicillin as an adequate therapy for acute cholangitis. Surg Gynecol Obstet 1990 ; 171 : 275-82.(治療レベル2b)
30) Thompson JE Jr, Bennion RS, Roettger R, Lally KP, Hopkins JA, Wilson SE. Cefepime for infections of the biliary tract. Surg Gynecol Obstet 1993 ; 177 Suppl : 30-4.(治療レベル2b)
31) Sung JJ, Lyon DJ, Suen R, Chung SC, Co AL, Cheng AF, et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis : a randomized, controlled clinical trial. J Antimicrob Chemother 1995 ; 35 : 855-64.(治療レベル2b)
32) Gilbert D, Moellering R Jr, Eliopoulos GM, Sande M. The Sanford Guide to antimicrobial therapy. 35rd ed. Hyde Park, VT : Antimicrobial Therapy, Inc, 2005.(治療レベル3)
33) 森本 健,木下博明,中谷守一,上田隆美,酒井克治,平田早苗,他.Panipenem/betamipronの胆汁・胆嚢壁移行および外科領域感染症に対する臨床使用経験.Chemotherapy 1991 ; 29 Suppl 3 : 572-84.(治療レベル4)
34) Leung JW, Chan CY, Lai CW, Ko TC, Cheng AF, French GL. Effect of biliary obstruction on the hepatic excretion of imipenem-cilastatin. Antimicrob Agents Chemother 1992 ; 36 : 2057-60.(治療レベル3b)
35) 谷村 弘,斉藤 徹,関谷 司,小林展章,日笠頼則.胆道感染症の化学療法(XIV)-Piperacillinの胆汁中移行と胆嚢組織濃度.Jpn J Antibiot 1981 ; 34 : 1401-9.(治療レベル4)
36) 品川長夫,真下由良,二郎啓二,松野正紀,力山 敏,平山 隆,他.外科領域感染症におけるTazobactam/ Piparacilinの基礎的・臨床的評価.Jpn J Antibiot 1995 ; 48 : 346-367.
37) 田村 隆,加藤彰,中島幹夫.Cefazolinの胆汁中移行について.日臨外会誌 1982 ; 43 : 1325-8.(治療レベル4)
38) 葛西洋一,中西昌美,沢田康夫,中村 孝,橋本伊久雄,三上二郎,他.Cefmetazolの臨床的研究-特に胆道系疾患について.Jpn J Antibiot 1979 ; 32 : 606-11.(治療レベル4)
39) 谷村 弘,小林展章,斎藤 徹,黄 文芳,吉田圭介,高橋 裕,他.胆道感染症の化学療法(209)6315-S(Flomoxef)の胆嚢組織内濃度,胆汁中移行および臨床効果について.Chemotherapy 1987 ; 35 Suppl1 : 852-73.(治療レベル4)
40) 西村興亜,河野菊弘,澄川 学,河村良寛,日前敏子,小立寿成,他.Cefotiamの胆汁中並びに胆嚢組織内移行に関する臨床的検討.Jpn J Antibiot 1984 ; 37 : 219-28.(治療レベル4)
41) Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994 ; 40 : 716-21.(治療レベル3b)
42) Orda R, Berger SA,evy Y, Shnaker A, Gorea A. Penetration of ceftriaxone and cefoperazone into bile and gallbladder tissue in patients with acute chlecystitis. Dig Dis Sci 1992 ; 37 : 1691-3.(治療レベル4)
43) 花谷勇治,福富隆志,横山 勲.外科領域におけるCeftazidimeの基礎的・臨床的検討.Chemotherapy 1983 ; 31 Suppl 3 : 683-90.
44) 松本文男,今井建郎,桜井 磐,岡部紀正,高橋孝行,森田雅之.Cefozopranに関する基礎的・臨床的検討.Chemotherapy 1993 ; 41 : 195-9.(治療レベル4)
45) 由良二郎,品川長夫,石川 周,城 義政,柴田純孝,河辺章夫.外科領域におけるCefpirome(CPR)の基礎的・臨床的検討.Chemotherapy 1991 ; 39 Suppl 1 : 379-85.(治療レベル4)
46) 谷村 弘,村上浩一,内山和久,福 昭人,平田公一,向谷充宏,他.Pazufloxacin注射薬の外科感染症における臨床効果及び体液・組織移行性の検討.Chemotherapy 1999 ; 7 Suppl 1 : 227-41.
47) Martinez O, Levi J, Devlin R. Biliary excretion of aztreonam in patients with biliary tract disease. Antimicrob Agents Chemother 1984 ; 25 : 358-61.(治療レベル4)
48) 清水武昭,土屋嘉昭,佐藤 攻.Meropenemの胆汁中移行および外科的感染症の臨床的検討.Chemotherapy 1992 ; 40 : 507-13.(治療レベル4)
49) Sales J, Sutcliffe M, O'Grady F. Excretion of clindamycin in the bile of patients with biliary tract disease. Chemotherapy 1973 ; 19 : 11-5.(治療レベル4)
50) Chacon JP, Criscuolo PD, Kobata CM, Ferraro JR, Saad SS, Reis C. Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infections. J Antimicrob Chemother 1990 ; 26 Suppl B : 167-72.(治療レベル2b)
51) Cunha B. Antibiotic Essentials. New York, NY : Stony Book, 2002(治療レベル3)
52) 日本感染症学会,日本化学療法学会.抗菌薬使用の手引き.協和企画,東京,2001.
53) 品川長夫.重症胆管炎の治療方針と抗菌薬の選択.胆と膵 1995 ; 16 : 569-74.(治療レベル5)
54) Marne C, Pallares R, Martin R, Sitges-Serra A. Gangrenous cholecystlithiasis and acute cholangitis associated with anaerobic bacteria in bile. European Journal of Clinical Microbiology 1986 ; 5 : 35-39.(診断レベル3b)
55) Claesson BE, Holmlund DE, Matzsch TW. Microflora of the gallbladder related to duration of acute cholecystitis. Surg Gynecol Obstet 1986 ; 162 : 531-5.(診断レベル2b)
56) Nielsen ML, Justesen T. Anaerobic and aerobic bacteriological studies in biliary tract disease. Scand J Gastroenterol 1976 ; 11 : 437-46.(診断レベル3b)
57) Investigators of the Piparacilin/Tazobactam intra-abdominal infection study group. Rrsults of the Noth American trial of Piparacilin/Tazobactam compared with Clindamycin and Gentamicin in the treatment of severe intra-abdominal infections. Eur J Surg 1994 ; Suppl 573 : 61-6.

 

書誌情報